
Drug Approvals in 2023
The year 2023 has seen a number of important drug approvals, both for new drugs and for new indications for existing drugs. Here are some of the most notable approvals:
* Dostarlimab: Dostarlimab is a first-in-class drug that has been approved for the treatment of advanced rectal cancer. Dostarlimab is a